NASDAQ:REPH

Recro Pharma News Headlines

$2.76
-0.02 (-0.72 %)
(As of 04/16/2021 04:00 PM ET)
Add
Compare
Today's Range
$2.64
Now: $2.76
$2.80
50-Day Range
$2.54
MA: $3.41
$5.04
52-Week Range
$1.49
Now: $2.76
$9.19
Volume283,435 shs
Average Volume627,547 shs
Market Capitalization$85.60 million
P/E Ratio13.80
Dividend YieldN/A
Beta1.25

Headlines

Recro Pharma (NASDAQ REPH) News Headlines Today

SourceHeadline
Recro Reports Inducement Grants for New StaffRecro Reports Inducement Grants for New Staff
finance.yahoo.com - April 6 at 7:43 AM
News for Recro Pharma IncNews for Recro Pharma Inc
markets.businessinsider.com - March 26 at 3:38 AM
Recro to Present at H.C. Wainwright Global Life Science ConferenceRecro to Present at H.C. Wainwright Global Life Science Conference
finance.yahoo.com - March 2 at 8:42 AM
Recro Reports Fourth Quarter and Year End 2020 Financial ResultsRecro Reports Fourth Quarter and Year End 2020 Financial Results
finance.yahoo.com - February 26 at 8:39 AM
Earnings Preview for Recro PharmaEarnings Preview for Recro Pharma
finance.yahoo.com - February 25 at 2:55 PM
Revisiting Recro PharmaRevisiting Recro Pharma
seekingalpha.com - February 17 at 9:26 AM
Recro Grants Inducement Award to New Chief Executive OfficerRecro Grants Inducement Award to New Chief Executive Officer
finance.yahoo.com - December 18 at 10:24 PM
Recro Announces Executive ChangesRecro Announces Executive Changes
finance.yahoo.com - December 16 at 8:23 AM
Is the Options Market Predicting a Spike in Recro Pharma (REPH) Stock?Is the Options Market Predicting a Spike in Recro Pharma (REPH) Stock?
finance.yahoo.com - December 15 at 12:21 PM
Oppenheimer Says These 2 Stocks Could Spike Over 100%Oppenheimer Says These 2 Stocks Could Spike Over 100%
finance.yahoo.com - December 11 at 3:48 PM
Recro Pharma, Inc. (REPH) CEO Geraldine Henwood on Q3 2020 Results - Earnings Call TranscriptRecro Pharma, Inc. (REPH) CEO Geraldine Henwood on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 10 at 9:57 AM
Recro Pharma (REPH) Q3 2020 Earnings Call TranscriptRecro Pharma (REPH) Q3 2020 Earnings Call Transcript
finance.yahoo.com - November 9 at 2:14 PM
Recro to Report Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 9, 2020Recro to Report Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 9, 2020
finance.yahoo.com - November 2 at 8:56 AM
Recro Pharma, Inc. (REPH)Recro Pharma, Inc. (REPH)
ca.finance.yahoo.com - August 10 at 9:11 PM
Recro Pharma EPS misses by $0.09, misses on revenueRecro Pharma EPS misses by $0.09, misses on revenue
seekingalpha.com - August 10 at 10:58 AM
Recro Reports Second Quarter 2020 Financial ResultsRecro Reports Second Quarter 2020 Financial Results
finance.yahoo.com - August 10 at 10:58 AM
Recro Pharma: Q2 Earnings InsightsRecro Pharma: Q2 Earnings Insights
finance.yahoo.com - August 10 at 10:58 AM
Is Recro Pharma Inc (REPH) A Good Stock To Buy?Is Recro Pharma Inc (REPH) A Good Stock To Buy?
finance.yahoo.com - July 5 at 10:27 PM
Edited Transcript of REPH earnings conference call or presentation 11-May-20 12:00pm GMTEdited Transcript of REPH earnings conference call or presentation 11-May-20 12:00pm GMT
finance.yahoo.com - May 28 at 8:06 AM
Recro Pharma down 41% on Q1 results; revenue guidance loweredRecro Pharma down 41% on Q1 results; revenue guidance lowered
seekingalpha.com - May 12 at 4:01 AM
Recro Pharma down 41% on tough Q1, guidance cutRecro Pharma down 41% on tough Q1, guidance cut
seekingalpha.com - May 11 at 6:00 PM
Recro Pharma, Inc. Investigated for Possible Securities Laws Violations by Block & Leviton; Investors Who Lost Money Should Contact the FirmRecro Pharma, Inc. Investigated for Possible Securities Laws Violations by Block & Leviton; Investors Who Lost Money Should Contact the Firm
finance.yahoo.com - May 11 at 6:00 PM
Recro to Report First Quarter 2020 Financial Results and Host Conference Call and Webcast on May 11, 2020Recro to Report First Quarter 2020 Financial Results and Host Conference Call and Webcast on May 11, 2020
finance.yahoo.com - May 8 at 7:31 AM
Recro Announces Change in Location of its 2020 Annual Meeting of Shareholders to its Corporate HeadquartersRecro Announces Change in Location of its 2020 Annual Meeting of Shareholders to its Corporate Headquarters
finance.yahoo.com - May 1 at 4:39 PM
Is Recro Pharma, Inc. (NASDAQ:REPH) A Volatile Stock?Is Recro Pharma, Inc. (NASDAQ:REPH) A Volatile Stock?
finance.yahoo.com - April 21 at 2:47 PM
Baudax Bio plans $25M stock sale to fund first product launchBaudax Bio plans $25M stock sale to fund first product launch
finance.yahoo.com - March 25 at 3:34 PM
Edited Transcript of REPH earnings conference call or presentation 4-Mar-20 1:00pm GMTEdited Transcript of REPH earnings conference call or presentation 4-Mar-20 1:00pm GMT
finance.yahoo.com - March 24 at 7:07 PM
60 Stocks Moving In Wednesdays Mid-Day Session60 Stocks Moving In Wednesday's Mid-Day Session
www.msn.com - March 4 at 1:39 PM
Soft guidance pressures Recro Pharma, down 26%Soft guidance pressures Recro Pharma, down 26%
seekingalpha.com - March 4 at 1:39 PM
Recro Pharma EPS beats by $0.76, misses on revenueRecro Pharma EPS beats by $0.76, misses on revenue
seekingalpha.com - March 4 at 8:38 AM
Recro Reports Financial Results for the Year Ended 2019Recro Reports Financial Results for the Year Ended 2019
finance.yahoo.com - March 4 at 8:38 AM
Recro to Report Year End 2019 Financial Results and Host Conference Call and Webcast on March 4, 2020Recro to Report Year End 2019 Financial Results and Host Conference Call and Webcast on March 4, 2020
finance.yahoo.com - March 2 at 8:38 AM
Tiny, Underfollowed Baudax Bio Way Too Cheap After Receiving FDA Drug ApprovalTiny, Underfollowed Baudax Bio Way Too Cheap After Receiving FDA Drug Approval
seekingalpha.com - February 24 at 2:32 PM
Recro Pharma (REPH) May Report Negative Earnings: Know the Trend Ahead of Q4 ReleaseRecro Pharma (REPH) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
finance.yahoo.com - February 11 at 1:15 PM
Im Adding This Pharma Company to My Top Stocks for 2020 ListI'm Adding This Pharma Company to My Top Stocks for 2020 List
realmoney.thestreet.com - February 6 at 1:28 PM
I'm Adding This Pharma Company to My Top Stocks for 2020 ListI'm Adding This Pharma Company to My Top Stocks for 2020 List
finance.yahoo.com - February 6 at 1:28 PM
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Recro Pharma, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of DirectorsSHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Recro Pharma, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
finance.yahoo.com - January 2 at 3:41 PM
Recro Pharma, Inc. Common Stock (REPH) Institutional HoldingsRecro Pharma, Inc. Common Stock (REPH) Institutional Holdings
www.nasdaq.com - January 1 at 9:48 PM
Recro Pharma completes split into two companiesRecro Pharma completes split into two companies
finance.yahoo.com - November 21 at 10:21 AM
Edited Transcript of REPH earnings conference call or presentation 8-Nov-19 1:00pm GMTEdited Transcript of REPH earnings conference call or presentation 8-Nov-19 1:00pm GMT
finance.yahoo.com - November 12 at 7:54 AM
Recro Pharma, Inc. (REPH) CEO Gerri Henwood on Q3 2019 Results - Earnings Call TranscriptRecro Pharma, Inc. (REPH) CEO Gerri Henwood on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 10 at 8:18 AM
Recro Pharma EPS misses by $0.03, beats on revenueRecro Pharma EPS misses by $0.03, beats on revenue
seekingalpha.com - November 8 at 9:51 AM
Recro Pharma Reports Third Quarter 2019 Financial ResultsRecro Pharma Reports Third Quarter 2019 Financial Results
markets.businessinsider.com - November 8 at 9:51 AM
Malvern pharma firm's board approves spinoff planMalvern pharma firm's board approves spinoff plan
finance.yahoo.com - November 5 at 5:58 PM
Recro Pharma to Report Third Quarter 2019 Financial Results and Host Conference Call and Webcast on November 8, 2019Recro Pharma to Report Third Quarter 2019 Financial Results and Host Conference Call and Webcast on November 8, 2019
finance.yahoo.com - November 5 at 5:58 PM
Recro Pharma’s Board of Directors Approves Separation of Acute Care Business Segment and Declares Special Dividend Distribution of Baudax Bio Common StockRecro Pharma’s Board of Directors Approves Separation of Acute Care Business Segment and Declares Special Dividend Distribution of Baudax Bio Common Stock
finance.yahoo.com - November 5 at 7:56 AM
Malvern pharma firm wins FDA appeal, moves forward with spinoff plansMalvern pharma firm wins FDA appeal, moves forward with spinoff plans
finance.yahoo.com - October 31 at 6:59 PM
Recro Pharma up 11% on appeal of IV meloxicam CRLRecro Pharma up 11% on appeal of IV meloxicam CRL
seekingalpha.com - October 31 at 1:54 PM
FDA Grants Appeal to Recro Pharma for IV Meloxicam New Drug ApplicationFDA Grants Appeal to Recro Pharma for IV Meloxicam New Drug Application
finance.yahoo.com - October 31 at 8:17 AM
Recro Pharma (REPH) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseRecro Pharma (REPH) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
finance.yahoo.com - October 30 at 12:27 PM
This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.